ZTS · Zoetis Inc. · Documents

Feb 13

Current report 8-K

Financial results

Feb 13

Annual report 10-K FY2024, ended Dec 31

Annual report for FY2024

Revenue $9.26B ▲ 8.3% Net income $2.49B ▲ 6.1% Diluted EPS $5.47 ▲ 7.9%

Feb 6

Current report 8-K

Regulation FD disclosure

Jan 13

Current report 8-K

Regulation FD disclosure

Dec 12

Current report 8-K

Regulation FD disclosure

Nov 12

Current report 8-K Events of Nov 11

Change in control, Other events

Nov 4

Earnings call

Q3 2024 earnings call

Nov 4

Current report 8-K

Financial results

Nov 4

Quarterly report 10-Q FY2024 Q3, ended Sep 30

Quarterly report for FY2024 Q3

Revenue $2.39B ▲ 11.0% Net income $682M ▲ 14.4% Diluted EPS $1.50 ▲ 16.3%

Oct 10

Current report 8-K

Regulation FD disclosure

Aug 6

Earnings call

Q2 2024 earnings call

Aug 6

Current report 8-K

Financial results

Aug 6

Quarterly report 10-Q FY2024 Q2, ended Jun 30

Quarterly report for FY2024 Q2

Revenue $2.36B ▲ 8.3% Net income $624M ▼ 7.0% Diluted EPS $1.37 ▼ 5.5%

Aug 1

Current report 8-K

Regulation FD disclosure

May 24

Current report 8-K Events of May 20

Director or officer change, or executive pay

May 23

Current report 8-K Events of May 21

Director or officer change, or executive pay, Charter or bylaw amendment, or fiscal year change, Shareholder vote results

May 22

Current report 8-K

Regulation FD disclosure

May 8

Proxy statement DEFA14A

Proxy statement

May 6

Proxy statement DEFA14A

Proxy statement

May 2

Earnings call

Q1 2024 earnings call

May 2

Current report 8-K

Financial results

May 2

Quarterly report 10-Q FY2024 Q1, ended Mar 31

Quarterly report for FY2024 Q1

Revenue $2.19B ▲ 9.5% Net income $599M ▲ 8.5% Diluted EPS $1.31 ▲ 10.1%

Apr 16

Current report 8-K

Director or officer change, or executive pay

Apr 10

Proxy statement DEF 14A Meeting May 22, 2024

Proxy statement

Apr 10

Annual report to holders ARS

Annual report to holders

Apr 10

Proxy statement DEFA14A

Proxy statement

Apr 1

Current report 8-K

Director or officer change, or executive pay

Mar 27

Proxy statement PRE 14A Meeting May 22, 2024

Proxy statement

Feb 13

Earnings call

Q4 2023 earnings call

Feb 13

Current report 8-K

Financial results

Feb 13

Annual report 10-K FY2023, ended Dec 31

Annual report for FY2023

Revenue $8.54B ▲ 5.7% Net income $2.34B ▲ 10.9% Diluted EPS $5.07 ▲ 12.9%

Feb 6

Current report 8-K

Regulation FD disclosure

Dec 7

Current report 8-K

Regulation FD disclosure

Nov 2

Earnings call

Q3 2023 earnings call

Nov 2

Current report 8-K

Financial results

Nov 2

Quarterly report 10-Q FY2023 Q3, ended Sep 30

Quarterly report for FY2023 Q3

Revenue $2.15B ▲ 7.4% Net income $596M ▲ 12.7% Diluted EPS $1.29 ▲ 14.2%

Oct 12

Current report 8-K

Regulation FD disclosure

Aug 8

Earnings call

Q2 2023 earnings call

Aug 8

Current report 8-K

Financial results

Aug 8

Quarterly report 10-Q FY2023 Q2, ended Jun 30

Quarterly report for FY2023 Q2

Revenue $2.18B ▲ 6.2% Net income $671M ▲ 26.8% Diluted EPS $1.45 ▲ 29.5%

May 25

Current report 8-K

Regulation FD disclosure

May 19

Current report 8-K Events of May 18

Charter or bylaw amendment, or fiscal year change, Shareholder vote results

May 11

Current report 8-K

Regulation FD disclosure

May 4

Earnings call

Q1 2023 earnings call

May 4

Current report 8-K

Financial results

May 4

Quarterly report 10-Q FY2023 Q1, ended Mar 31

Quarterly report for FY2023 Q1

Revenue $2B ▲ 0.7% Net income $552M ▼ 7.2% Diluted EPS $1.19 ▼ 5.6%

Apr 6

Proxy statement DEF 14A

Proxy statement

Apr 6

Annual report to holders ARS

Annual report to holders

Apr 6

Proxy statement DEFA14A

Proxy statement

Mar 22

Proxy statement PRE 14A

Proxy statement